At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NAGE Niagen Bioscience
Closed 12-09 16:00:00 EST
6.51
+0.02
+0.31%
盘后6.51
+0.000.00%
18:02 EST
High6.58Low6.41Vol925.37K
Open6.42D1 Closing6.49Amplitude2.62%
Mkt Cap520.28MTradable Cap334.71MTotal Shares79.92M
T/O6.03MT/O Rate1.80%Tradable Shares51.41M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Niagen Bioscience management to meet with Roth Capital
TIPRANKS  ·  11-26
Niagen Bioscience management to meet with Roth Capital
Niagen Bioscience Announces $10 Million Share Repurchase Program
Reuters  ·  11-20
Niagen Bioscience Announces $10 Million Share Repurchase Program
Niagen Bioscience CFO Pamir Ozan Acquires Common Shares
Reuters  ·  11-17
Niagen Bioscience CFO Pamir Ozan Acquires Common Shares
Correction: Niagen Says Long COVID Trial Exploring Supplement Failed to Show 'Statistically Significant Differences' in Meeting Endpoints Versus Placebo Groups
MT Newswires Live  ·  11-13
Correction: Niagen Says Long COVID Trial Exploring Supplement Failed to Show 'Statistically Significant Differences' in Meeting Endpoints Versus Placebo Groups
Niagen Bioscience announces results of Niagen supplementation in long COVID
TIPRANKS  ·  11-13
Niagen Bioscience announces results of Niagen supplementation in long COVID
Niagen Bioscience Reports Clinical Trial Shows Niagen Supplement Boosts NAD+ and Eases Long COVID Symptoms
Reuters  ·  11-13
Niagen Bioscience Reports Clinical Trial Shows Niagen Supplement Boosts NAD+ and Eases Long COVID Symptoms
We Think Niagen Bioscience's (NASDAQ:NAGE) Profit Is Only A Baseline For What They Can Achieve
Simply Wall St.  ·  11-11
We Think Niagen Bioscience's (NASDAQ:NAGE) Profit Is Only A Baseline For What They Can Achieve
Niagen Bioscience Approves $10 Million Stock Buyback Program
MT Newswires Live  ·  11-07
Niagen Bioscience Approves $10 Million Stock Buyback Program
Stock Track | Niagen Bioscience Soars 6.25% Following $10 Million Share Repurchase Announcement
Stock Track  ·  11-06
Stock Track | Niagen Bioscience Soars 6.25% Following $10 Million Share Repurchase Announcement
Stock Track | Niagen Bioscience Soars 6.25% on $10 Million Share Repurchase Program Announcement
Stock Track  ·  11-06
Stock Track | Niagen Bioscience Soars 6.25% on $10 Million Share Repurchase Program Announcement
Niagen Bioscience Announces $10 Million Share Buyback
TIPRANKS  ·  11-06
Niagen Bioscience Announces $10 Million Share Buyback
Stock Track | Niagen Bioscience Soars 6.10% Pre-market on $10 Million Share Repurchase Announcement
Stock Track  ·  11-06
Stock Track | Niagen Bioscience Soars 6.10% Pre-market on $10 Million Share Repurchase Announcement
Stock Track | Niagen Bioscience Soars 6.10% Pre-market on $10 Million Share Buyback Announcement
Stock Track  ·  11-06
Stock Track | Niagen Bioscience Soars 6.10% Pre-market on $10 Million Share Buyback Announcement
BRIEF-Niagen Bioscience Announces $10 Million Share Repurchase Program
Reuters  ·  11-06
BRIEF-Niagen Bioscience Announces $10 Million Share Repurchase Program
Niagen Bioscience Inc. Publishes Transcript of Third Quarter 2025 Earnings Conference Call
Reuters  ·  11-06
Niagen Bioscience Inc. Publishes Transcript of Third Quarter 2025 Earnings Conference Call
Niagen Bioscience Is Maintained at Buy by Canaccord Genuity
Dow Jones  ·  11-06
Niagen Bioscience Is Maintained at Buy by Canaccord Genuity
Niagen Bioscience price target lowered to $14 from $16 at Canaccord
TIPRANKS  ·  11-05
Niagen Bioscience price target lowered to $14 from $16 at Canaccord
Niagen Bioscience Inc reports results for the quarter ended September 30 - Earnings Summary
Reuters  ·  11-05
Niagen Bioscience Inc reports results for the quarter ended September 30 - Earnings Summary
Niagen Bioscience Inc. unveils investor presentation highlighting NAD+ market growth and product pipeline
Reuters  ·  11-05
Niagen Bioscience Inc. unveils investor presentation highlighting NAD+ market growth and product pipeline
Niagen Bioscience Q3 sales beat estimates on strong e-commerce performance
Reuters  ·  11-05
Niagen Bioscience Q3 sales beat estimates on strong e-commerce performance

Introduction

Company Name.
Niagen Bioscience
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--